Presented at #ASCO24 :

ASC4FIRST: Asciminib, an agent that targets the myristoyl pocket of BCR::ABL, was compared with imatinib and with imatinib plus second-generation tyrosine kinase inhibitors. Outcomes were better with aciminib in both comparisons. nej.md/4bNNr3c

Original Article: Asciminib in Newly Diagnosed Chronic Myeloid Leukemia (ASC4FIRST) nej.md/4bNNr3c

#ASCO24 | ASCO

Just published the results of ASC4FIRST showing superior efficacy and safety of asciminib versus standard TKIs as frontline therapy for CML. Georgia Cancer Center Andreas Hochhaus Tim Hughes International CML Foundation (iCMLf) nejm.org/doi/full/10.10…

Pünktlich zum #InternationalerKindertag begrüßen wir Professor Till Milde Universität Jena und als neuen Direktor der Klinik für Kinder- und Jugendmedizin. Herzlich Willkommen in Jena - Lichtstadt!
➡️t1p.de/an587

📣 THE MAIN SCIENTIFIC TOPICS OF #ESHCMLMPN2025 !
Registration & abstract submission here ➡ bit.ly/4cjz0oy
4th How to Diagnose and Treat CML/MPN
🗓️ March 7-9, 2025 in Vienna 🇦🇹
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa Ruben A. Mesa, MD
#ESHCONFERENCES #MPNsm #CMLsm

🗳️Heute heißt es: Wählen gehen & CDU wählen‼️
#Kommunalwahl #CDU #Thüringen

Is this 5*100mg + 2* Oh-my-god or zero milligrams? :-) #cmlhz24

📊 Andreas Hochhaus presents new data on first-line treatment in CML, offering fresh insights for patients and practitioners alike. Stay informed about the latest advancements! #CMLHZ24

Thank you so much Andreas Hochhaus for always keeping us up-to-date!!!

✨ We are kicking off Medical Session 2 with Prof Andreas Hochhaus talking about what have we learned for predictors of Successful TFR from a Drs perspective!
#CMLHZ24

Amazing session at #CMLHZ24 where we are discussing a truly global perspective on TFR in high, middle and low income countries, including perspectives from clinicians, nurses and patient advocates from different regions. A true 360 degree view we can’t see at any medical conf.

Allogene Stammzelltransplantation - Mindestmengen

Gemeinsame Stellungnahme der DGHO, der DAG-HSZT und der Deutschen Leukämie- und Lymphomhilfe

dgho.de/aktuelles/news…

📅 Mark your calendars & Save the Date for World CML Day 2024! 🌟

We are thrilled to announce the rollout of our toolkit, beginning with Stage 1, for this important event dedicated to raising awareness and supporting the fight against Chronic Myeloid Leukemia. 🌏 Join us as we

Don't miss the symposium at FLI on May 27, 2024, in which Dr. Ron DePinho (Dept. of #Cancer #Biology , University of Texas MD Anderson Cancer Center) will give a lecture on 'Genetics and Biology of Pancreas Cancer, and its Cure':👉leibniz-fli.de/de/news-events…

von Eyss lab Andreas Hochhaus #CCCG

Now published, asciminib showing high efficacy and tolerability in CML-CP with T315I. Honored to work with such great team of collaborators and friends. Georgia Cancer Center Valentin Garcia DGJR Andreas Hochhaus michael mauro Tim Hughes International CML Foundation (iCMLf) link.springer.com/article/10.103…

Künstliche Intelligenz in der Hämatologie und Medizinischen Onkologie

21. Band der Gesundheitspolitischen Schriftenreihe der DGHO erschienen!

dgho.de/publikationen/…

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients | Leukemia nature.com/articles/s4137…

Ready for an inside look at #EHA ? Make sure to join us for this year's Annual General Meeting (AGM) on June 14 at #EHA 2024 in Madrid or online. Hear from EHA President Antonio Almeida about what members can expect from this year's meeting 👇

Learn more: eha.fyi/AGM_2024

Erfolgreiche DGHO-Frühjahrstagung

'Politik und Medizin' ist das gesund? Diese Frage lässt sich pauschal nicht beantworten. Aber: Wenn Politik und Medizin im Dialog stehen, ist es möglich. Die DGHO hat alle Akteure an einen Tisch gebracht.

dgho.de/aktuelles/news…

DGHO fordert ein Verbot von Aromen in E-Zigaretten
Gemeinsam mit der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin sowie weiteren wissenschaftlichen medizinischen Fachgesellschaften hat die DGHO ein Positionspapier erarbeitet.

dgho.de/aktuelles/news…